Evaluation of Amygdalin (B17) and Cucurbita pepo (Pumpkin seed) Activity Against Blastocystis from Diarrheic Patients in Baghdad, Iraq: in Vitro Study

Main Article Content

Saba S. Salman
Naksheen M. Ardalan

Abstract

Blastocystis is a ubiquitous human and animal protozoa that inhabit the gastrointestinal tract. Metronidazole is considered the standard drug for the treatment of Blastocystis infection; however, there is growing evidence of treatment failure, hazardous side effects, and appearance of strains resistant to metronidazole. In the last era, many studies have been implicated in the quest for new treatments for Blastocystis infection, especially natural products. Attention has been focused on the effect of Amygdalin (B17) and pumpkin seed on eradicating parasitic infections. The current work was built up to explore the in vitro efficacy of two natural compounds, Amygdalin (B17) and pumpkin seeds against Blastocystis isolated from symptomatic patients. In vitro incubation of the parasite with B17 (200, 400µgmL¯¹), pumpkin seed (200, 400 µgmL¯¹) and metronidazole (100, 150µgmL¯¹) was counted at different periods (one, two, twenty-four and forty-eight hours) and morphological changes were evaluated using Light Microscope. Blastocystis detected from patients with symptoms was subtype 1. The B 17 and pumpkin seed demonstrated statistically significant (p<0.05) growth reduction of Blastocystis in culture. Such results showed the possible therapeutic effects of B 17 and pumpkin seed against blastocystosis as effective safe natural alternatives.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Salman SS, Ardalan NM. Evaluation of Amygdalin (B17) and Cucurbita pepo (Pumpkin seed) Activity Against Blastocystis from Diarrheic Patients in Baghdad, Iraq: in Vitro Study. Baghdad Sci.J [Internet]. [cited 2021Aug.3];19(1):0016. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/4893
Section
article

References

Sulekova LF, Gabrielli S, Furze F, Milardi GL, Bilotti E, De Angelis M, et al. Molecular characterization of Blastocystis subtypes in HIV-positive patients and evaluation of risk factors for colonization. BMC Infect Dis. 2019;19(1):1–7.

Alfellani MA, Stensvold CR, Vidal-Lapiedra A, Onuoha ES, Fagbenro-Beyioku AF, Clark CG. Variable geographic distribution of Blastocystis subtypes and its potential implications. Acta Trop. 2013;126(1):11–8.

Lepczyńska M, Chen W, Dzika E. Mysterious chronic urticaria caused by Blastocystis spp.? Int J Dermatol. 2016;55(3):259–66.

As farm S, Daryani A, Sarvi S, Pagheh AS, Hosseini SA, Saberi R, et al. Geospatial analysis and epidemiological aspects of human infections with Blastocystis hominis in Mazandaran Province, northern Iran. Epidemiol Health. 2019;41.

Stensvold CR, Nielsen H V, Mølbak K, Smith H V. Pursuing the clinical significance of Blastocystis–diagnostic limitations. Trends Parasitol. 2009;25(1):23–9.

Khademvatan S, Masjedizadeh R, Rahim F, Mahbodfar H, Salehi R, Yousefi-Razin E, et al. Blastocystis and irritable bowel syndrome: Frequency and subtypes from Iranian patients. Parasitol Int. 2017;66(2):142–5.

Ramírez JD, Sánchez A, Hernández C, Flórez C, Bernal MC, Giraldo JC, et al. Geographic distribution of human Blastocystis subtypes in South America. Infect Genet Evol. 2016;41:32–5.

Ismail S, Ali I, Fahmy Z, Azmy M, Magdy M. Susceptibility of Blastocystis hominis to monolaurin (lauric acid), lactoferrin (Lactobacillus acidophilus) and metronidazole: an in vitro and in vivo studies. Afr J Pharm Pharmacol. 2016;10(21):14–25.

Mirza H, Teo JDW, Upcroft J, Tan KSW. A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities. Antimicrob Agents Chemother. 2011;55(2):637–48.

El-Sayed SH, Amer N, Ismail S, Ali I, Rizk E, Magdy M, et al. In vitro and in vivo anti-Blastocystis efficacy of olive leaf extract and bee pollen compound. Res J Parasitol. 2017;12:33–44.

Mirmiranpour H, Khaghani S, Zandieh A, Khalilzadeh OO, Gerayesh-Nejad S, Morteza A, et al. Amygdalin inhibits angiogenesis in the cultured endothelial cells of diabetic rats. Indian J Pathol Microbiol. 2012;55(2):211.

Chang H-K, Shin M-S, Yang H-Y, Lee J-W, Kim Y-S, Lee M-H, et al. Amygdalin induces apoptosis through regulation of Bax and Bcl-2 expressions in human DU145 and LNCaP prostate cancer cells. Biol Pharm Bull. 2006;29(8):1597–602.

Qadir M, Fatima K. Review on the pharmacological activity of amygdalin. Arch Can Res. 2017;5(4):160.

Liu C, Li X, Yang H, Mao X, Wang J, Gao W. Effect of natural β‐glucosidase inhibitors in reducing the toxicity of amygdalin in persicae semen. Phytother Res. 2017;31(5):771–7.

Yadav M, Jain S, Tomar R, Prasad G, Yadav H. Medicinal and biological potential of pumpkin: an updated review. Nutr Res Rev. 2010;23(2):184–90.

Lens C, Turner N, Khan T, Brauer G. Ethnoveterinary medicines used to treat endoparasites and stomach problems in pigs and pets in British Columbia, Canada. Vet Parasitol. 2007;148(3–4):325–40.

Leelayoova S, Taamasri P, Rangsin R, Naaglor T, Thathaisong U, Mungthin M. In-vitro cultivation: a sensitive method for detecting Blastocystis hominis. Ann Trop Med Parasitol. 2002;96(8):803–7.

Mahmood MN, Ramadan FN, Hassan MS, Sabry HY, Magdy MM. Introducing Miltefosine as an anti-cryptosporidial agent in immunocompromised mice. J Plant Pathol Microbiol. 2016;7(354):2.

Padukone S, Mandal J, Rajkumari N, Bhat BV, Swaminathan RP, Parija SC. Detection of Blastocystis in clinical stool specimens using three different methods and morphological examination in Jones’ medium. Trop Parasitol. 2018;8(1):33.

Stensvold CR. Comparison of sequencing (barcode region) and sequence-tagged-site PCR for Blastocystis subtyping. J Clin Microbiol. 2013;51(1):190–4.

Sawangjaroen N, Sawangjaroen K. The effects of extracts from anti-diarrheic Thai medicinal plants on the in vitro growth of the intestinal protozoa parasite: Blastocystis hominins. J Ethnopharmacol. 2005;98(1–2):67–72.

Stenzel DJ, Boreham PF. Blastocystis hominis revisited. Clin Microbiol Rev. 1996;9(4):563–84.

Kurt Ö, Al FD, Tanyüksel M. Eradication of Blastocystis in humans: Necessary for all? Parasitol Int. 2016;65(6):797–801.

Rajamanikam A, Hooi HS, Kudva M, Saudi C, Kumar S. Resistance towards metronidazole in Blastocystis sp.: A pathogenic consequence. PLoS One. 2019;14(2).

Naß J, Efferth T. The activity of Artemisia spp. and their constituents against Trypanosomiasis. Phytomedicine. 2018;47:184–91.

Organization WH. The promotion and development of traditional medicine: report of a WHO meeting [held in Geneva from 28 November to 2 December 1977]. World Health Organization; 1978.

Al-Ani AAJ, S Albakri H. Molecular characterization of Blastocystis sp. isolates from human, cattle, and sheep by restriction fragment length polymorphism (RFLP) analysis of the small subunit ribosomal RNA gene. Iraqi J Vet Sci. 2016;30(1):1–7.

Nghaimesh SK, Mohammad NS, Kader MA. Gene sequencing of Blastocystis hominis and its association with H. pylori in the development of irritable bowel syndrome. kirkuk university journal for scientific studies. 2018;13(1):289-303.

Cakir F, Cicek M, Yildirim IH. Determination the subtypes of Blastocystis sp. and evaluate the effect of these subtypes on pathogenicity. Acta Parasitol. 2019;64(1):7–12.

Jiménez PA, Jaimes JE, Ramírez JD. A summary of Blastocystis subtypes in North and South America. Parasit Vectors. 2019;12(1):376.

Holzbecher MD, Moss MA, Ellenberger HA. The cyanide content of laetrile preparations, apricot, peach, and apple seeds. J Toxicol Clin Toxicol. 1984;22(4):341–7.

Mani J, Neuschäfer J, Resch C, Rutz J, Maxeiner S, Roos F, et al. Amygdalin modulates prostate cancer cell adhesion and migration in vitro. Nutr Cancer. 2019;1–10.

Yang Y, Zhao J, Song X, Li L, Li F, Shang J, et al. Amygdalin reduces lipopolysaccharide-induced chronic liver injury in rats by downregulating PI3K/AKT, JAK2/STAT3, and NF-κB signaling pathways. Artif cells, nanomedicine, Biotechnol. 2019;47(1):2688–97.

Song Z, Xu X. Advanced research on anti-tumor effects of amygdalin. J Cancer Res Ther. 2014;10(5):3.

Kim MY, Kim EJ, Kim Y-N, Choi C, Lee B-H. Comparison of the chemical compositions and nutritive values of various pumpkin (Cucurbitaceae) species and parts. Nutr Res Pract. 2012;6(1):21–7.

Hammer KA, Carson CF, Riley T V. Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol. 1999;86(6):985–90.

Adebayo JO, Adewole KE, Krettli AU. Cysteine-stabilized peptide extract of Morinda Lucida (Benth) leaf exhibits antimalarial activity and augments the antioxidant defense system in P. berghei-infected mice. J Ethnopharmacol. 2017;207:118–28.

Amorim CZ, Marques AD, Cordeiro RSB. Screening of the antimalarial activity of plants of the Cucurbitaceae family. Mem Inst Oswaldo Cruz. 1991;86:177–80.

Mullai K, Jebanesan A. Larvicidal, ovicidal, and repellent activities of the leaf extract of two cucurbitacious plants against filarial vector Culex quinquefasciatus (Say)(Diptera: Culicidae). Trop Biomed. 2007;24(1):1–6.

Marie-Magdeleine C, Hoste H, Mahieu M, Varo H, Archimede H. In vitro effects of Cucurbita moschata seed extracts on Haemonchus contortus. Vet Parasitol. 2009;161(1–2):99–105.

Aziz ARA, AbouLaila MR, Aziz M, Omar MA, Sultan K. In vitro and in vivo anthelmintic activity of pumpkin seeds and pomegranate peels extracts against Ascaridia galli. Beni-Suef Univ J Basic Appl Sci. 2018;7(2):231–4.

Kinyua CM. Modeling and Application of Response Surface Methodology for Optimization of Weight Gain of Eight Weeks Old Kenbro Served With Pumpkin (Cucurbita Pepo L) Seeds Extract. Chuka University; 2019.

Mokhtar AB, El-Gaydar EK, Habib AS. In vitro anti-protozoal activity of propolis extract and cysteine proteases inhibitor (phenyl vinyl sulfone) on Blastocystis species. J Egypt Soc Parasitol. 2016;240(3825):1–12.

Yakoob J, Abbas Z, Beg MA, Naz S, Awan S, Hamid S, et al. In vitro sensitivity of Blastocystis hominis to garlic, ginger, white cumin, and black pepper used in the diet. Parasitol Res. 2011;109(2):379–85.

Roberts T, Bush S, Ellis J, Harkness J, Stark D. In vitro antimicrobial susceptibility patterns of Blastocystis. Antimicrob Agents Chemother. 2015;59(8):4417–23.